“…To date, many genetic factors have been known, which indirectly lead to disorders of platelet-vascular hemostasis and are trigger factors for disorders of fibrinolysis [1-3, 17, 24]. Of particular interest is the polymorphism of the platelet receptor fibrinogen (GP IIIa), which is associated with a disturbance of the metabolism of homocysteine, the low concentration of which causes bleeding [4,13,21,22]. Today, 18 mutations of the GP IIIa gene are known.…”